Skip to content

Comparison of 2 drug combinations for sedation in cervical cancer patients undergoing radiotherapy

Comparative evaluation of Dexmedetomidine-Ketamine versus Ketamine-Propofol for sedation and analgesia in cervical cancer patients for intra cavitary brachytherapy: A prospective randomized double blind study - NIL

Status
Active, not recruiting
Phases
Phase 4
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2024/03/063806
Enrollment
46
Registered
2024-03-07
Start date
Unknown
Completion date
Unknown
Last updated
2024-04-01

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: O- Medical and Surgical

Interventions

Intervention1: IV Drug combination (Dexket): Dexmedetomidine 0/5mic per kg and ketamine 1 mg per kg IV over 2 minutes. Hemodynamics were followed every 5 min for 30 min and hourly for 6 hours. Interve

Sponsors

Ananta institute of medical sciences
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: Patients of cervical cancer scheduled for elective brachytherapy Patients aged between 20-70 years ASA I, II

Exclusion criteria

Exclusion criteria: History of cardiovascular diseases e.g. ischaemic heart disease,conduction defects, etc. History of compromised renal / hepatic / neuronal functions. Uncontrolled hypertension and Diabetes Pregnant or lactating women. History alcohol, substance abuse, chronic use of analgesic and sedatives, psychiatric disorders Patients on b blocker or having persistent bradycardia with HR30 min

Design outcomes

Primary

MeasureTime frame
Onset and recovery of sedationTimepoint: Baseline, 1,2,5,7,10,15,20,25 and 30 minutes.

Secondary

MeasureTime frame
Intraoperative Haemodynamics (Heart Rate,Blood Pressure, Spo2, Respiratory rate) Post op recovery score (Modified Aldrete Score) Duration of analgesiaTimepoint: Baseline, 1, 2,5,7,10,15,20,25 & 30 minutes & then hourly for 6 hours.

Countries

India

Contacts

Public ContactDr Nirdesh Thakore

Ananta institute of medical sciences

drnirdeshthakore87@gmail.com9461347316

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026